Jacob R. Manjarrez
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Jacob R. Manjarrez has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Robert L. Matts
Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, OK, USA
5 shared publications Brenda Tinoco-Bravo
Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, United States
2 shared publicationsCrystal A. Shults
Oklahoma State University Center for Health Sciences, Tulsa, OK, United States
2 shared publicationsCrystal Shults
Biochemistry and Microbiology, Oklahoma State University Center for Health Sciences, Tulsa, OK, US
2 shared publicationsLiang Sun
Department of Biochemistry and Molecular Biology, Oklahoma State University, Stillwater, Oklahoma, United States of America
2 shared publicationsMagera Shaw
University of Tulsa
2 shared publications
Latest Publications
- Open Access
- 4 September 2026
- Published by Caltech Library in microPublication Biology
- No. 10
A Simple Pluronic F-127 Pretreatment Enables Near-Complete Recovery of C. elegans from Plastic Pipette Tips and Microcentrifuge Tubes
- 4 September 2026
- Published by Caltech Library in microPublication Biology
- No. 10
Open AccessA Simple Pluronic F-127 Pretreatment Enables Near-Complete Recovery of C. elegans from Plastic Pipette Tips and Microcentrifuge Tubes
- Open Access
- 27 June 2026
- Vol. 2026
Effects of Vitamin C Supplementation on Tetrabenazine Treatment in a Caenorhabditis elegans Huntington's Disease Model.
Tetrabenazine, a VMAT2 inhibitor, is widely used to treat chorea in Huntington's disease by depleting monoamine neurotransmitters, particularly dopamine. However, this mechanism may indirectly increase oxidative stress due to enhanced metabolism and auto‑oxidation of cytosolic monoamines, generating reactive oxygen species. Using Caenorhabditis elegans polyglutamine models, this study investigated the effects of tetrabenazine and vitamin C supplementation on survival. These results indicate that tetrabenazine reduces survival, while vitamin C, a known antioxidant, mitigates these effects and improves outcomes, particularly in pathogenic poly‑Q strains. Our findings suggest that antioxidant supplementation may counteract tetrabenazine‑associated oxidative stress and enhance therapeutic efficacy in neurodegenerative disease.
- 27 June 2026
- Vol. 2026
Open AccessEffects of Vitamin C Supplementation on Tetrabenazine Treatment in a Caenorhabditis elegans Huntington's Disease Model.
Tetrabenazine, a VMAT2 inhibitor, is widely used to treat chorea in Huntington's disease by depleting monoamine neurotransmitters, particularly dopamine. However, this mechanism may indirectly increase oxidative stress due to enhanced metabolism and auto‑oxidation of cytosolic monoamines, generating reactive oxygen species. Using Caenorhabditis elegans polyglutamine models, this study investigated the effects of tetrabenazine and vitamin C supplementation on survival. These results indicate that tetrabenazine reduces survival, while vitamin C, a known antioxidant, mitigates these effects and improves outcomes, particularly in pathogenic poly‑Q strains. Our findings suggest that antioxidant supplementation may counteract tetrabenazine‑associated oxidative stress and enhance therapeutic efficacy in neurodegenerative disease.
- Open Access
- 19 June 2026
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 17, 1885864
Short CAG repeat variation as a regulatory factor in health and disease
Short cytosine-adenine-guanine (CAG) trinucleotide repeats, which encode polyglutamine (polyQ) tracts, are prevalent features of genes enriched in transcriptional and regulatory functions, including the androgen receptor (AR) and huntingtin (HTT). While expanded CAG repeats are well established in neurodegenerative disease pathogenesis, the functional significance of short, non-pathogenic repeat lengths remains underappreciated. This review connects evidence demonstrating that short CAG/polyQ tracts act as dynamic modulators of protein conformation, transcriptional activity, and protein-protein interactions. Variation within physiological repeat ranges influences receptor sensitivity, cellular signaling, and phenotypic diversity. The AR serves as a central model, where shorter repeat lengths enhance transactivation and androgen responsiveness and are associated with increased prostate cancer risk, while longer non-expanded repeats are linked to reduced receptor activity and modest reproductive and metabolic effects. Mechanistically, repeat length and sequence composition jointly influence repeat stability, RNA structure, and downstream regulatory processes. Beyond AR, short CAG variation contributes to neuropsychiatric phenotypes and broader regulatory networks. Collectively, short CAG repeats function as quantitative regulators of gene activity, shaping disease susceptibility, physiological variation, and evolutionary adaptation.
- 19 June 2026
- Published by Frontiers Media SA in Frontiers in Genetics
- Vol. 17, 1885864
Open AccessShort CAG repeat variation as a regulatory factor in health and disease
Short cytosine-adenine-guanine (CAG) trinucleotide repeats, which encode polyglutamine (polyQ) tracts, are prevalent features of genes enriched in transcriptional and regulatory functions, including the androgen receptor (AR) and huntingtin (HTT). While expanded CAG repeats are well established in neurodegenerative disease pathogenesis, the functional significance of short, non-pathogenic repeat lengths remains underappreciated. This review connects evidence demonstrating that short CAG/polyQ tracts act as dynamic modulators of protein conformation, transcriptional activity, and protein-protein interactions. Variation within physiological repeat ranges influences receptor sensitivity, cellular signaling, and phenotypic diversity. The AR serves as a central model, where shorter repeat lengths enhance transactivation and androgen responsiveness and are associated with increased prostate cancer risk, while longer non-expanded repeats are linked to reduced receptor activity and modest reproductive and metabolic effects. Mechanistically, repeat length and sequence composition jointly influence repeat stability, RNA structure, and downstream regulatory processes. Beyond AR, short CAG variation contributes to neuropsychiatric phenotypes and broader regulatory networks. Collectively, short CAG repeats function as quantitative regulators of gene activity, shaping disease susceptibility, physiological variation, and evolutionary adaptation.
- Open Access
- 22 May 2026
- Vol. 2026
Behavioral and Morphological Effects of Natural Sweeteners on Caenorhabditis elegans
Caenorhabditis elegans is an attractive, genetically tractable model organism widely used to investigate morphological and locomotor responses to environmental and dietary factors. This study examined the effects of the natural alternative sweeteners, Stevia in the Raw®, Truvia®, Lakanto®, and Monkfruit in the Raw®. Worms were exposed to each sweetener through their growth media, and behavioral (crawling and swimming speed, wavelength, and activity) and morphological (length, width, and area) parameters were quantified using WormLab. The objective was to evaluate the effects on development and behavior using natural alternative sweeteners relative to conventional granulated white sugar when administered in equivalent amounts.
- 22 May 2026
- Vol. 2026
Open AccessBehavioral and Morphological Effects of Natural Sweeteners on Caenorhabditis elegans
Caenorhabditis elegans is an attractive, genetically tractable model organism widely used to investigate morphological and locomotor responses to environmental and dietary factors. This study examined the effects of the natural alternative sweeteners, Stevia in the Raw®, Truvia®, Lakanto®, and Monkfruit in the Raw®. Worms were exposed to each sweetener through their growth media, and behavioral (crawling and swimming speed, wavelength, and activity) and morphological (length, width, and area) parameters were quantified using WormLab. The objective was to evaluate the effects on development and behavior using natural alternative sweeteners relative to conventional granulated white sugar when administered in equivalent amounts.
- Open Access
- 12 September 2023
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 14, 1207705
Probiotic effects of Lactococcus lactis and Leuconostoc mesenteroides on stress and longevity in Caenorhabditis elegans
The short lifespan of Caenorhabditis elegans enables the efficient investigation of probiotic interventions affecting stress and longevity involving the potential therapeutic value of Lactococcus lactis and Leuconostoc mesenteroides isolated from organic basil. The lactic acid bacteria were cultured from the produce collected from a local grocery store in Tulsa, Oklahoma, and then identified through 16S rDNA sequencing and biochemical tests. To dive deep into this analysis for potential probiotic therapy, we used fluorescent reporters that allow us to assess the differential induction of multiple stress pathways such as oxidative stress and the cytoplasmic, endoplasmic reticulum, and the mitochondrial unfolded protein response. This is combined with the classic health span measurements of survival, development, and fecundity, allowing a wide range of organismal observations of the different communities of microbes supported by probiotic supplementation with Lactococcus lactis and Leuconostoc mesenteroides. These strains were initially assessed in relation to the Escherichia coli feeding strain OP50 and the C. elegans microbiome. The supplementation showed a reduction in the median lifespan of the worms colonized within the microbiome. This was unsurprising, as negative results are common when probiotics are introduced into healthy microbiomes. To further assess the supplementation potential of these strains on an unhealthy (undifferentiated) microbiome, the typical axenic C. elegans diet, OP50, was used to simulate this single-species biome. The addition of lactic acid bacteria to OP50 led to a significant improvement in the median and overall survival in simulated biomes, indicating their potential in probiotic therapy. The study analyzed the supplemented cultures in terms of C. elegans’ morphology, locomotor behavior, reproduction, and stress responses, revealing unique characteristics and stress response patterns for each group. As the microbiome’s influence on the health span gains interest, the study aims to understand the microbiome relationships that result in differential stress resistance and lifespans by supplementing microbiomes with Lactococcus lactis and Leuconostoc mesenteroides isolated from organic basil in C. elegans.
- 12 September 2023
- Published by Frontiers Media SA in Frontiers in Physiology
- Vol. 14, 1207705
Open AccessProbiotic effects of Lactococcus lactis and Leuconostoc mesenteroides on stress and longevity in Caenorhabditis elegans
The short lifespan of Caenorhabditis elegans enables the efficient investigation of probiotic interventions affecting stress and longevity involving the potential therapeutic value of Lactococcus lactis and Leuconostoc mesenteroides isolated from organic basil. The lactic acid bacteria were cultured from the produce collected from a local grocery store in Tulsa, Oklahoma, and then identified through 16S rDNA sequencing and biochemical tests. To dive deep into this analysis for potential probiotic therapy, we used fluorescent reporters that allow us to assess the differential induction of multiple stress pathways such as oxidative stress and the cytoplasmic, endoplasmic reticulum, and the mitochondrial unfolded protein response. This is combined with the classic health span measurements of survival, development, and fecundity, allowing a wide range of organismal observations of the different communities of microbes supported by probiotic supplementation with Lactococcus lactis and Leuconostoc mesenteroides. These strains were initially assessed in relation to the Escherichia coli feeding strain OP50 and the C. elegans microbiome. The supplementation showed a reduction in the median lifespan of the worms colonized within the microbiome. This was unsurprising, as negative results are common when probiotics are introduced into healthy microbiomes. To further assess the supplementation potential of these strains on an unhealthy (undifferentiated) microbiome, the typical axenic C. elegans diet, OP50, was used to simulate this single-species biome. The addition of lactic acid bacteria to OP50 led to a significant improvement in the median and overall survival in simulated biomes, indicating their potential in probiotic therapy. The study analyzed the supplemented cultures in terms of C. elegans’ morphology, locomotor behavior, reproduction, and stress responses, revealing unique characteristics and stress response patterns for each group. As the microbiome’s influence on the health span gains interest, the study aims to understand the microbiome relationships that result in differential stress resistance and lifespans by supplementing microbiomes with Lactococcus lactis and Leuconostoc mesenteroides isolated from organic basil in C. elegans.
- Open Access
Optogenetic analysis of Ca ++ transients in Caenorhabditis elegans muscle cells during forward and reverse locomotion
Understanding how an organism generates movement is an important step toward determining how a system of neurons produces behavior. With only 95 body wall muscles and 302 neurons, Caenorhabditis elegans is an attractive model organism to use in uncovering the connection between neural circuitry and movement. This study provides a comprehensive examination of the muscle cell activity used by C. elegans during both forward and reverse locomotion. By tracking freely moving worms that express genetically encoded calcium indicators in their muscle cells, we directly measure the patterns of activity that occur during movement. We then analyzed these patterns using a variety of signal processing and statistical techniques. Although our results agree with many previous findings, we also discovered there is significantly different mean Ca ++ levels in many of the muscle cells during forward and reverse locomotion and, when considered independently, the dorsal and ventral muscle activation waves exhibit classical neuromechanical phase lag (NPL).
Open AccessOptogenetic analysis of Ca ++ transients in Caenorhabditis elegans muscle cells during forward and reverse locomotion
Understanding how an organism generates movement is an important step toward determining how a system of neurons produces behavior. With only 95 body wall muscles and 302 neurons, Caenorhabditis elegans is an attractive model organism to use in uncovering the connection between neural circuitry and movement. This study provides a comprehensive examination of the muscle cell activity used by C. elegans during both forward and reverse locomotion. By tracking freely moving worms that express genetically encoded calcium indicators in their muscle cells, we directly measure the patterns of activity that occur during movement. We then analyzed these patterns using a variety of signal processing and statistical techniques. Although our results agree with many previous findings, we also discovered there is significantly different mean Ca ++ levels in many of the muscle cells during forward and reverse locomotion and, when considered independently, the dorsal and ventral muscle activation waves exhibit classical neuromechanical phase lag (NPL).
- Open Access
- 8 January 2015
- Published by Oxford University Press (OUP) in Genetics
- Vol. 199 (3) , 729-737
Unusual Regulation of Splicing of the Cholinergic Locus inCaenorhabditis elegans
The essential neurotransmitter acetylcholine functions throughout the animal kingdom. In Caenorhabditis elegans, the acetylcholine biosynthetic enzyme (choline acetyltransferase; ChAT) and vesicular transporter (vesicular acetylcholine transporter; VAChT) are encoded by the cha-1 and unc-17 genes, respectively. These two genes comprise a single complex locus in which the unc-17 gene is nested within the first intron of cha-1, and the two gene products arise from a common pre-mRNA by alternative splicing. This genomic organization, known as the Cholinergic Gene Locus (CGL), is conserved throughout the animal kingdom, suggesting that the structure is important for the regulation and function of these genes. However, very little is known about CGL regulation in any species. We now report the identification of an unusual type of splicing regulation in the CGL of C. elegans, mediated by two pairs of complementary sequence elements within the locus. We show that both pairs of elements are required for efficient splicing to the distal acceptor, and we also demonstrate that proper distal splicing depends more on sequence complementarity within each pair of elements than on the sequences themselves. We propose that these sequence elements are able to form stem-loop structures in the pre-mRNA; such structures would favor specific splicing alternatives, and thus regulate CGL splicing. We have identified complementary elements at comparable locations in the genomes of representative species of other animal phyla; we suggest that this unusual regulatory mechanism may be a general feature of CGLs.
- 8 January 2015
- Published by Oxford University Press (OUP) in Genetics
- Vol. 199 (3) , 729-737
Open AccessUnusual Regulation of Splicing of the Cholinergic Locus inCaenorhabditis elegans
The essential neurotransmitter acetylcholine functions throughout the animal kingdom. In Caenorhabditis elegans, the acetylcholine biosynthetic enzyme (choline acetyltransferase; ChAT) and vesicular transporter (vesicular acetylcholine transporter; VAChT) are encoded by the cha-1 and unc-17 genes, respectively. These two genes comprise a single complex locus in which the unc-17 gene is nested within the first intron of cha-1, and the two gene products arise from a common pre-mRNA by alternative splicing. This genomic organization, known as the Cholinergic Gene Locus (CGL), is conserved throughout the animal kingdom, suggesting that the structure is important for the regulation and function of these genes. However, very little is known about CGL regulation in any species. We now report the identification of an unusual type of splicing regulation in the CGL of C. elegans, mediated by two pairs of complementary sequence elements within the locus. We show that both pairs of elements are required for efficient splicing to the distal acceptor, and we also demonstrate that proper distal splicing depends more on sequence complementarity within each pair of elements than on the sequences themselves. We propose that these sequence elements are able to form stem-loop structures in the pre-mRNA; such structures would favor specific splicing alternatives, and thus regulate CGL splicing. We have identified complementary elements at comparable locations in the genomes of representative species of other animal phyla; we suggest that this unusual regulatory mechanism may be a general feature of CGLs.
- Open Access
- 7 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e90054
Hsp90-Dependent Assembly of the DBC2/RhoBTB2-Cullin3 E3-Ligase Complex
The expression of the wild-type tumor-suppressor gene DBC2 (Deleted-in-Breast Cancer 2, a.k.a RhoBTB2) is suppressed in many cancers, in addition to breast cancer. In a screen for Cdc37-associated proteins, DBC2 was identified to be a potential client protein of the 90 kDa heat shock protein (Hsp90) chaperone machine. Pull down assays of ectopically expressed DBC2 confirmed that DBC2 associated with Hsp90 and its co-chaperone components in reticulocyte lysate and MCF7 cells. Similar to other atypical Rho GTPases, DBC2 was found to have retained the capacity to bind GTP. The ability of DBC2 to bind GTP was modulated by the Hsp90 ATPase cycle, as demonstrated through the use of the Hsp90 chemical inhibitors, geldanamycin and molybdate. The binding of full length DBC2 to GTP was suppressed in the presence of geldanamycin, while it was enhanced in the presence of molybdate. Furthermore, assembly of DBC2-Cullin3-COP9 E3 ligase complexes was Hsp90-dependent. The data suggest a new paradigm for Hsp90-modulated assembly of a Cul3/DBC2 E3 ubiquitin ligase complex that may extend to other E3 ligase complexes.
- 7 March 2014
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 9 (3) , e90054
Open AccessHsp90-Dependent Assembly of the DBC2/RhoBTB2-Cullin3 E3-Ligase Complex
The expression of the wild-type tumor-suppressor gene DBC2 (Deleted-in-Breast Cancer 2, a.k.a RhoBTB2) is suppressed in many cancers, in addition to breast cancer. In a screen for Cdc37-associated proteins, DBC2 was identified to be a potential client protein of the 90 kDa heat shock protein (Hsp90) chaperone machine. Pull down assays of ectopically expressed DBC2 confirmed that DBC2 associated with Hsp90 and its co-chaperone components in reticulocyte lysate and MCF7 cells. Similar to other atypical Rho GTPases, DBC2 was found to have retained the capacity to bind GTP. The ability of DBC2 to bind GTP was modulated by the Hsp90 ATPase cycle, as demonstrated through the use of the Hsp90 chemical inhibitors, geldanamycin and molybdate. The binding of full length DBC2 to GTP was suppressed in the presence of geldanamycin, while it was enhanced in the presence of molybdate. Furthermore, assembly of DBC2-Cullin3-COP9 E3 ligase complexes was Hsp90-dependent. The data suggest a new paradigm for Hsp90-modulated assembly of a Cul3/DBC2 E3 ubiquitin ligase complex that may extend to other E3 ligase complexes.
- 1 June 2012
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1823 (6) , 1092-1101
Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins
- 1 June 2012
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
- Vol. 1823 (6) , 1092-1101
Characterization of the interaction of Aha1 with components of the Hsp90 chaperone machine and client proteins